A randomised, double-blind, parallel group, phase 3, efficacy and safety study of AZD6140 compared with Clopidogrel for Prevention of Vascular Events in Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS) [PLATO- a Study of PLATe let Inhibition and Patient Outcomes] - Harrington, R